Evidence map›Paper›PMID 39389373›Full record

ReviewChemosphere2024

Neurotoxicology of warfare arsenical, diphenylarsinic acid in humans and experimental models.

Shalini Saggu, Ritesh K Srivastava, Lisa McCormick, Anupam Agarwal, Mohammad Moshahid Khan, Mohammad Athar

Abstract readReview
In one paragraph

Review in Chemosphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shalini SagguDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, GA, 30912, USA; UAB Research Centre of Excellence in Arsenicals, Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Ritesh K SrivastavaUAB Research Centre of Excellence in Arsenicals, Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Lisa McCormickDepartment of Environmental Health Science, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Anupam AgarwalDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Mohammad Moshahid KhanDepartment of Neurology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Mohammad AtharUAB Research Centre of Excellence in Arsenicals, Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. Electronic address: mohammadathar@uabmc.edu.

Funding

UAB Research Center of Excellence in ArsenicalsU54ES030246 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AHMAD, AFTAB · 2018 to 2022
$19.0M
Optimization of Novel Molecular Target-based Drugs for Arsenical Skin InjuryU01AR078544 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ATHAR, MOHAMMAD · 2020 to 2024
$3.9M
NIAMS NIH HHS U01 AR078544NIEHS NIH HHS U54 ES030246
6 · The paper itself

Abstract

Unused warfare chemical agents, developed in World Wars I/II dumped in the ocean or buried at various sites across the world, pose significant environmental and human health risks. This review provides description of the neurotoxicity of arsenic-based warfare chemicals known as arsenicals. We specifically described the neuropathogenesis of diphenylarsinic acid (DPAA), a chemical warfare-related organoarsenicals and a degradation product of diphenylchloroarsine (DA), diphenylcyanoarsine (DC), also known as Clark I and Clark II respectively. These arsenicals are potent emetics, which were buried at a former naval base in the town of Kamisu, Japan. Several decades after burial, their environmental decay led to contamination of underground water table. Consumption of the contaminated water by the residents manifested a neurological syndrome, which was associated with damage to the cerebellum and brainstem as well as behavioral deficits. We summarized the chronology of this damage as recorded by monitoring the exposed population over time (∼15 years). Several simulating animal studies in primates and murine models demonstrate that DPAA caused this syndrome.

Indexed as

ArsenicalsAnimalsChemical Warfare AgentsHumansJapanMiceNeurotoxicity SyndromesWater Pollutants, ChemicalArsenicalsChemical Warfare Agentsdiphenylarsinic acidWater Pollutants, ChemicalBehavioral functionCerebellar-brainstem dysfunctionClarks I and IIDPAANeurotoxicityWarfare agents

Identifiers

PMID39389373
PMCPMC11588031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.